Barclays PLC — Major Shareholding Notification 2021

May 12, 2021

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

Ap19

FORM 8.3 - Amendment to purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

	Name of person dealing (Note 1)	Barclays PLC.
	Company dealt in	WILLIS TOWERS WATSON PLC
	Class of relevant security to which the	ORD
	dealings being disclosed relate (Note 2)
	Date of dealing	10 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		1,713,598	1.33%	183,952	0.14%
(2)	Derivatives (other than options):
		72,359	0.06%	0	0.00%
(3)	Options and agreements to
	purchase/sell:	6,100	0.00%	6,100	0.00%
	TOTAL:
		1,792,057	1.39%	190,052	0.15%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	2	269.9000 USD
Purchase	4	270.0585 USD
Purchase	6	271.6200 USD
Purchase	15	268.0000 USD
Purchase	100	268.9700 USD
Purchase	100	269.3400 USD
Purchase	100	270.9400 USD
Purchase	200	269.0350 USD
Purchase	200	269.4350 USD
Purchase	201	271.2635 USD
Purchase	202	268.8990 USD
Purchase	211	271.2093 USD
Purchase	314	269.3227 USD
Purchase	400	268.8692 USD
Purchase	400	271.2291 USD
Purchase	400	269.5200 USD
Purchase	471	269.8436 USD
Purchase	612	268.8901 USD
Purchase	1,200	269.0391 USD
Purchase	1,210	271.2778 USD
Purchase	1,451	268.9450 USD
Purchase	1,535	269.1147 USD
Purchase	2,063	269.8957 USD
Purchase	3,131	269.5106 USD
Purchase	3,712	269.0729 USD
Purchase	4,453	269.4805 USD
Purchase	4,702	269.3644 USD
Purchase	4,809	269.6670 USD
Purchase	10,279	269.1893 USD
Purchase	10,558	269.9276 USD
Purchase	11,200	269.5790 USD
Purchase	11,741	268.9367 USD
Purchase	33,259	268.8800 USD
Sale	1	269.6875 USD
Sale	3	270.1633 USD
Sale	5	271.1300 USD
Sale	6	270.0585 USD
Sale	15	268.0000 USD
Sale	42	269.7300 USD
Sale	100	270.3300 USD
Sale	100	271.3700 USD
Sale	100	271.5600 USD
Sale	161	269.5868 USD
Sale	200	270.0450 USD
Sale	200	269.6700 USD
Sale	219	270.4804 USD
Sale	221	268.7853 USD
Sale	300	270.8150 USD
Sale	376	269.1044 USD
Sale	400	270.0775 USD
Sale	553	269.5234 USD
Sale	554	270.0512 USD
Sale	600	269.4216 USD
Sale	832	271.1062 USD
Sale	899	269.7746 USD
Sale	1,500	269.6148 USD
Sale	2,022	269.5700 USD
Sale	2,133	269.8366 USD
Sale	2,313	269.9912 USD
Sale	2,424	269.6740 USD
Sale	2,830	269.5626 USD
Sale	2,925	269.7494 USD
Sale	3,163	269.4790 USD
Sale	3,306	269.5681 USD
Sale	3,500	269.0042 USD
Sale	3,868	269.5000 USD
Sale	4,101	269.8197 USD
Sale	11,741	268.9367 USD
Sale	16,093	268.8810 USD
Sale	17,371	268.8800 USD
Sale	22,442	269.2094 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	YES
Date of disclosure:	12 May 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Put Options	Purchased	-100	220.0000	American	Jul 16, 2021
Call Options	Purchased	100	240.0000	American	Jul 16, 2021
Call Options	Purchased	6,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-6,000	200.0000	American	Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210512005795/en/

BARCLAYS PLC